# OnKure Therapeutics, Inc.: filings

OKUR · Nasdaq · CIK 1637715 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/okur.md) · [Financials](/companies/okur/financials.md) · [Filings](/companies/okur/filings.md) · [Insiders](/companies/okur/insiders.md)

## Reports and events: 100 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 133, 8-K 54, 3 35, 10-Q 17, SCHEDULE 13G/A 14, SCHEDULE 13G 12, 424B3 11, CORRESP 11, SC 13G 11, EFFECT 9, S-8 8, UPLOAD 8, SC 13D/A 7, SC 13G/A 6, 10-K 5, S-3 5, SC 13D 5, 424B5 4, 425 4, D 4, DEF 14A 4, DEFA14A 4, ARS 3, S-4/A 3, 144 2, 4/A 2, POS AM 2, S-1 2, SCHEDULE 13D 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 10-K/A 1, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, S-1/A 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 22:22 ET | [8-K](/filings/0001193125-26-347315.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-347315 |
| 2026-08-04 | 20:10 ET | [8-K](/filings/0001193125-26-332809.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332809 |
| 2026-08-04 | 20:05 ET | [10-Q](/filings/0001193125-26-332773.md) | Quarterly report, period 2026-06-30 | 0001193125-26-332773 |
| 2026-06-04 | 20:15 ET | [8-K](/filings/0001193125-26-257423.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-257423 |
| 2026-05-05 | 20:10 ET | [8-K](/filings/0001193125-26-206396.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206396 |
| 2026-05-05 | 20:05 ET | [10-Q](/filings/0001193125-26-206345.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206345 |
| 2026-04-21 | 20:15 ET | [DEF 14A](/filings/0001140361-26-015903.md) | Proxy statement, period 2026-06-03 | 0001140361-26-015903 |
| 2026-04-07 | 01:14 ET | [SCHEDULE 13D](/filings/0001193125-26-146025.md) | Ownership report, active investor | 0001193125-26-146025 |
| 2026-03-30 | 10:01 ET | [8-K](/filings/0001193125-26-130283.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-130283 |
| 2026-03-12 | 20:10 ET | [10-K](/filings/0001193125-26-104147.md) | Annual report, period 2025-12-31 | 0001193125-26-104147 |
| 2026-03-12 | 20:05 ET | [8-K](/filings/0001193125-26-104104.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-104104 |
| 2025-11-06 | 21:23 ET | [8-K](/filings/0001193125-25-269652.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-269652 |
| 2025-11-06 | 21:13 ET | [10-Q](/filings/0001193125-25-269540.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269540 |
| 2025-11-06 | 21:06 ET | [8-K](/filings/0001193125-25-269468.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269468 |
| 2025-08-12 | 20:20 ET | [10-Q](/filings/0001193125-25-178981.md) | Quarterly report, period 2025-06-30 | 0001193125-25-178981 |
| 2025-08-12 | 20:20 ET | [8-K](/filings/0001193125-25-178978.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-178978 |
| 2025-06-26 | 20:16 ET | [8-K](/filings/0000950170-25-090403.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-090403 |
| 2025-05-30 | 19:57 ET | [SCHEDULE 13D/A](/filings/0001636587-25-000030.md) | Ownership report, active investor, amended | 0001636587-25-000030 |
| 2025-05-28 | 20:30 ET | [8-K](/filings/0000950170-25-078375.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-078375 |
| 2025-05-22 | 20:49 ET | [SCHEDULE 13D](/filings/0001636587-25-000027.md) | Ownership report, active investor | 0001636587-25-000027 |
| 2025-05-06 | 11:40 ET | [10-Q](/filings/0000950170-25-063970.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063970 |
| 2025-05-06 | 11:35 ET | [8-K](/filings/0000950170-25-063969.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063969 |
| 2025-04-16 | 20:23 ET | [DEF 14A](/filings/0001140361-25-014183.md) | Proxy statement, period 2025-05-27 | 0001140361-25-014183 |
| 2025-03-10 | 20:15 ET | [8-K](/filings/0000950170-25-036306.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036306 |
| 2025-03-10 | 20:05 ET | [10-K](/filings/0000950170-25-036252.md) | Annual report, period 2024-12-31 | 0000950170-25-036252 |
| 2025-01-21 | 23:38 ET | [SCHEDULE 13D/A](/filings/0001104659-25-004963.md) | Ownership report, active investor, amended | 0001104659-25-004963 |
| 2024-12-10 | 12:05 ET | [8-K](/filings/0000950170-24-134757.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-134757 |
| 2024-11-07 | 21:05 ET | [8-K](/filings/0000950170-24-123265.md) | 4.01 Change of auditor; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-123265 |
| 2024-11-07 | 21:00 ET | [10-Q](/filings/0000950170-24-123233.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123233 |
| 2024-10-23 | 21:03 ET | [S-1](/filings/0001193125-24-241926.md) | Registration statement | 0001193125-24-241926 |
| 2024-10-08 | 23:34 ET | [SC 13D/A](/filings/0001072613-24-000769.md) | Ownership report, active investor, amended | 0001072613-24-000769 |
| 2024-10-08 | 21:26 ET | [8-K](/filings/0001193125-24-234487.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-234487 |
| 2024-10-02 | 21:20 ET | [8-K](/filings/0001193125-24-231281.md) | 5.07 Shareholder vote results | 0001193125-24-231281 |
| 2024-09-20 | 11:00 ET | [8-K](/filings/0001193125-24-222429.md) | 8.01 Other events | 0001193125-24-222429 |
| 2024-09-13 | 20:21 ET | [8-K](/filings/0001193125-24-218879.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-218879 |
| 2024-08-13 | 21:03 ET | [10-Q](/filings/0000950170-24-096411.md) | Quarterly report, period 2024-06-30 | 0000950170-24-096411 |
| 2024-08-13 | 20:00 ET | [8-K](/filings/0000950170-24-096127.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096127 |
| 2024-05-13 | 13:14 ET | [8-K](/filings/0001193125-24-136785.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-136785 |
| 2024-05-08 | 20:33 ET | [SC 13D/A](/filings/0001072613-24-000437.md) | Ownership report, active investor, amended | 0001072613-24-000437 |
| 2024-05-07 | 20:03 ET | [10-Q](/filings/0000950170-24-054452.md) | Quarterly report, period 2024-03-31 | 0000950170-24-054452 |
| 2024-05-07 | 20:00 ET | [8-K](/filings/0000950170-24-054442.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-054442 |
| 2024-04-26 | 10:16 ET | [10-K/A](/filings/0000950170-24-048631.md) | Annual report, amended, period 2023-12-31 | 0000950170-24-048631 |
| 2024-03-28 | 20:01 ET | [10-K](/filings/0000950170-24-038009.md) | Annual report, period 2023-12-31 | 0000950170-24-038009 |
| 2024-03-28 | 20:00 ET | [8-K](/filings/0000950170-24-038003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-038003 |
| 2024-02-23 | 21:00 ET | [8-K](/filings/0000950170-24-019338.md) | 2.05 Exit or disposal costs | 0000950170-24-019338 |
| 2023-12-26 | 22:00 ET | [SC 13D](/filings/0001214659-23-016861.md) | Ownership report, active investor | 0001214659-23-016861 |
| 2023-12-15 | 21:55 ET | [SC 13D/A](/filings/0001193125-23-296752.md) | Ownership report, active investor, amended | 0001193125-23-296752 |
| 2023-12-14 | 14:26 ET | [8-K](/filings/0001193125-23-295039.md) | 2.05 Exit or disposal costs; 8.01 Other events | 0001193125-23-295039 |
| 2023-11-13 | 21:05 ET | [10-Q](/filings/0000950170-23-062910.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062910 |
| 2023-11-13 | 21:00 ET | [8-K](/filings/0000950170-23-062888.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062888 |

Page 1 of 2. [Older](/companies/okur/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.